TrialClinical and vaccine immunology : CVI2008

Safety and immunogenicity of two influenza virus subunit vaccines, with or without MF59 adjuvant, administered to human immunodeficiency virus type 1-seropositive and -seronegative adults.

P Durando et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.